UN Photo/Christopher Black Events | 01 February 2023 MSF statements at WHO Executive Board 152nd session 1 min UN Photo/Christopher Black UN Photo/Christopher Black MSF representatives will speak at the 152nd session of the WHO Executive Board (EB) on a number of topics. Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min Don't miss out! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -EventsIssue briefLetterPress releaseSpeechStatement Statement | 24 January 2018 Tropical & neglected diseases 142nd WHO EB Agenda item 4.1 - Global snakebite burden statement Statement | 24 January 2018 Tuberculosis 142nd WHO EB Agenda item 3.9 - Preparation for a high-level meeting of the General Assembly on ending tuberculosis Statement | 24 January 2018 Intellectual property and trade Research and development 142nd WHO EB Agenda item 3.7 - Global strategy and plan of action on public health, innovation and intellectual property Statement | 24 January 2018 Vaccines 142nd WHO EB Agenda item 3.6 - Addressing the global shortage of, and access to, medicines and vaccines Issue brief Issue brief | 24 January 2018 Tropical & neglected diseases 142nd WHO EB Agenda item 4.1 - Global snakebite burden Issue brief Issue brief | 01 January 2018 Vaccines 142nd WHO EB Agenda item 6.2 - Global vaccine action plan Statement | 26 January 2017 Vaccines 140th WHO EB - Intervention - Agenda Item 9.1 Global Vaccine Action Plan Events | 23 January 2017 MSF briefings and interventions at WHO Executive Board 140th session Load More
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min
Statement | 24 January 2018 Tropical & neglected diseases 142nd WHO EB Agenda item 4.1 - Global snakebite burden statement
Statement | 24 January 2018 Tuberculosis 142nd WHO EB Agenda item 3.9 - Preparation for a high-level meeting of the General Assembly on ending tuberculosis
Statement | 24 January 2018 Intellectual property and trade Research and development 142nd WHO EB Agenda item 3.7 - Global strategy and plan of action on public health, innovation and intellectual property
Statement | 24 January 2018 Vaccines 142nd WHO EB Agenda item 3.6 - Addressing the global shortage of, and access to, medicines and vaccines
Issue brief Issue brief | 24 January 2018 Tropical & neglected diseases 142nd WHO EB Agenda item 4.1 - Global snakebite burden
Issue brief Issue brief | 01 January 2018 Vaccines 142nd WHO EB Agenda item 6.2 - Global vaccine action plan
Statement | 26 January 2017 Vaccines 140th WHO EB - Intervention - Agenda Item 9.1 Global Vaccine Action Plan
